This article bears witness to how much we fall in love with novelties, and how much we, as a scientific community, do not know yet about a fashionable autologous blood product. This case report is now one year old, and the situation in this field remains unchanged: randomised controlled trials show in a fairly unequivocable fashion that PRP use is at best dubious, and nevertheless case series report success. This should make us think, and use strict stringent scientific methods to plan and evaluate new technologies.